Table 3:

Characteristics and outcomes of patients admitted to hospital with SARS-CoV-2 infection, stratified by disposition

VariableNo. (%) of patients*
Total
n = 656
Died
n = 156
Discharged
n = 492
Age group, yr
 < 5073 (11.1)0 (0.0)72 (14.6)
 50–5985 (13.0)8 (5.1)77 (15.7)
 60–6971 (10.8)9 (5.8)61 (12.4)
 70–79125 (19.1)25 (16.0)98 (19.9)
 ≥ 80302 (46.0)114 (73.1)184 (37.4)
Sex, female349 (53.2)70 (44.9)275 (55.9)
Level of intervention (n = 645)
 1304 (47.1)9 (5.8)291 (60.5)
 255 (8.5)15 (9.6)39 (8.1)
 3214 (33.2)65 (41.7)147 (30.6)
 472 (11.2)67 (42.9)4 (0.8)
Patients not living in residential care353 (53.8)45 (28.8)302 (61.4)
Patients living in residential care303 (46.2)111 (71.2)190 (38.6)
 Public long-term care facilities153 (23.3)54 (34.6)98 (19.9)
 Private residential care facilities105 (16.0)41 (26.3)63 (12.8)
 Public intermediate care facilities45 (6.9)16 (10.3)29 (5.9)
No. of comorbidities
 0103 (15.7)4 (2.6)97 (19.7)
 1120 (18.3)17 (10.9)101 (20.5)
 2145 (22.1)35 (22.4)108 (22.0)
 3111 (16.9)32 (20.5)78 (15.9)
 ≥ 4177 (27.0)68 (43.6)108 (22.0)
Presence of fever, cough or URTI at admission422 (64.3)108 (69.2)309 (62.8)
Hypoxemia (n = 652)240 (36.8)90 (57.7)148 (30.3)
Length of symptoms, d, median (IQR) (n = 550)6.0 (3.0–10.0)4.0 (2.0–7.0)7.0 (3.0–10.0)
Hospital course and outcome
 ICU admission118 (18.0)26 (16.7)89 (18.1)
 Intubated (n = 132)69 (52.3)17 (51.5)49 (51.0)
 Length of intubation, d, median (IQR), (n = 56)12.5 (8.0–17.5)5.0 (2.5–9.5)12.0 (9.0–15.0)
 Length of ICU stay, d, median (IQR), (n = 117)11.0 (4.0–18.0)9.0 (3.0–18.0)11.0 (5.0–17.0)
 Length of hospital stay, d, median (IQR), (n = 647)11.0 (6.0–23.0)9.0 (5.0–16.0)12.0 (6.0–25.0)
Complications in hospital
 Acute respiratory distress syndrome (n = 654)97 (14.8)43 (27.7)51 (10.4)
 Venous thrombotic events (n = 654)30 (4.6)3 (1.9)26 (5.3)
 Acute kidney injury (n = 626)111 (17.7)54 (35.1)55 (11.8)
 Liver enzyme abnormalities (n = 653)77 (11.8)16 (10.3)60 (12.2)
  • Note: ICU = intensive care unit, IQR = interquartile range, URTI = symptoms of upper respiratory tract infection.

  • * Unless indicated otherwise.

  • Venous thrombotic events refer to pulmonary embolism or deep vein thrombosis.